These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1297 related items for PubMed ID: 9815297

  • 1. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
    Do T, Parker RG, Do C, Tran L, Do L, Dolkar D.
    Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297
    [Abstract] [Full Text] [Related]

  • 2. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):714-24. PubMed ID: 15708249
    [Abstract] [Full Text] [Related]

  • 3. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P, Katcher J, Levin H, Zippe C, Suh J, Macklis R, Klein E.
    Cancer J Sci Am; 1997 Mar 01; 3(2):78-87. PubMed ID: 9099457
    [Abstract] [Full Text] [Related]

  • 4. Is anastomotic biopsy necessary before radiotherapy after radical prostatectomy?
    Koppie TM, Grossfeld GD, Nudell DM, Weinberg VK, Carroll PR.
    J Urol; 2001 Jul 01; 166(1):111-5. PubMed ID: 11435834
    [Abstract] [Full Text] [Related]

  • 5. [Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: comparisons among ASTRO and Phoenix biochemical failure definitions].
    Quero L, Mongiat-Artus P, Ravery V, Hennequin V, Maylin C, Desgrandchamps F, Hennequin C.
    Cancer Radiother; 2009 Jul 01; 13(4):267-75. PubMed ID: 19446487
    [Abstract] [Full Text] [Related]

  • 6. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
    MacDonald OK, Schild SE, Vora S, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW.
    Urology; 2004 Oct 01; 64(4):760-4. PubMed ID: 15491716
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
    Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK.
    Urology; 2004 Jul 01; 64(1):84-9. PubMed ID: 15245941
    [Abstract] [Full Text] [Related]

  • 8. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
    Kupelian P, Thames H, Levy L, Horwitz E, Martinez A, Michalski J, Pisansky T, Sandler H, Shipley W, Zelefsky M, Zietman A, Kuban D.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):795-9. PubMed ID: 15925452
    [Abstract] [Full Text] [Related]

  • 9. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.
    Bianco FJ, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):448-53. PubMed ID: 15890586
    [Abstract] [Full Text] [Related]

  • 10. Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy.
    Neuhof D, Hentschel T, Bischof M, Sroka-Perez G, Hohenfellner M, Debus J.
    Int J Radiat Oncol Biol Phys; 2007 Apr 01; 67(5):1411-7. PubMed ID: 17275204
    [Abstract] [Full Text] [Related]

  • 11. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
    Paparel P, Cronin AM, Savage C, Scardino PT, Eastham JA.
    Eur Urol; 2009 Feb 01; 55(2):404-10. PubMed ID: 18639970
    [Abstract] [Full Text] [Related]

  • 12. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy.
    Geinitz H, Riegel MG, Thamm R, Astner ST, Lewerenz C, Zimmermann F, Molls M, Nieder C.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):1930-7. PubMed ID: 21514736
    [Abstract] [Full Text] [Related]

  • 13. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
    Shariat SF, Abdel-Aziz KF, Roehrborn CG, Lotan Y.
    Eur Urol; 2006 Feb 01; 49(2):293-302. PubMed ID: 16387412
    [Abstract] [Full Text] [Related]

  • 14. Salvage radiation for a rising PSA following radical prostatectomy.
    Maier J, Forman J, Tekyi-Mensah S, Bolton S, Patel R, Pontes JE.
    Urol Oncol; 2004 Feb 01; 22(1):50-6. PubMed ID: 14969805
    [Abstract] [Full Text] [Related]

  • 15. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels.
    Rogers E, Ohori M, Kassabian VS, Wheeler TM, Scardino PT.
    J Urol; 1995 Jan 01; 153(1):104-10. PubMed ID: 7526002
    [Abstract] [Full Text] [Related]

  • 16. Salvage radiotherapy for biochemical recurrence after radical prostatectomy.
    Terai A, Matsui Y, Yoshimura K, Arai Y, Dodo Y.
    BJU Int; 2005 Nov 01; 96(7):1009-13. PubMed ID: 16225518
    [Abstract] [Full Text] [Related]

  • 17. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.
    Chaplin BJ, Wildhagen MF, Schroder FH, Kirkels WJ, Bangma CH.
    Eur Urol; 2005 Dec 01; 48(6):906-10. PubMed ID: 16126322
    [Abstract] [Full Text] [Related]

  • 18. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
    Wiegel T, Lohm G, Bottke D, Höcht S, Miller K, Siegmann A, Schostak M, Neumann K, Hinkelbein W.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1009-16. PubMed ID: 18963539
    [Abstract] [Full Text] [Related]

  • 19. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?
    King CR, Presti JC, Gill H, Brooks J, Hancock SL.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):341-7. PubMed ID: 15145146
    [Abstract] [Full Text] [Related]

  • 20. Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy. A long term follow-up.
    Medini E, Medini I, Reddy PK, Levitt SH.
    Cancer; 1996 Sep 15; 78(6):1254-9. PubMed ID: 8826948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.